APLN and metabolic syndrome: Nevertheless, there is a limitation to its application as a best practice to reduce apelin levels for all obese women, since the study results were obtained from middle-aged women, who were more likely to experience sudden changes in hormones due to menopause and have the risk of exposure to metabolic syndrome.